ARCHIVES

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

This article is from The Cancer Letter archive.

Vol. 31 No. 30 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

DCT Advisors Approve Five Trials For High Priority Status

April 7, 1995

Hammer, ACS Agree n Procedures for Award Of Facilities Survey Contract

March 30, 1984

Walter Curran Succeeds Brian Leyland-Jones As Director Of Emory’s Cancer Center

September 25, 2009

Senate Bill Gives NIH $23.7 Billion, NCI $4.25 Billion, Better Than House.

November 2, 2001

In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor

January 6, 1989

In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished

February 12, 1988